These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11405600)

  • 41. Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma.
    Paramita DK; Fachiroh J; Haryana SM; Middeldorp JM
    J Clin Virol; 2008 Aug; 42(4):343-52. PubMed ID: 18455473
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjögren's syndrome patients with pulmonary involvements.
    Yamazaki M; Kitamura R; Kusano S; Eda H; Sato S; Okawa-Takatsuji M; Aotsuka S; Yanagi K
    Clin Exp Immunol; 2005 Mar; 139(3):558-68. PubMed ID: 15730403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enzyme-linked immunosorbent assay for detection of antibodies to Epstein-Barr virus antigens.
    Voevodin AF; Pácsa AS
    Acta Microbiol Hung; 1983; 30(2):125-9. PubMed ID: 6318497
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of bacterially expressed GST/EBNA-1 fusion proteins for detection of antibodies in sera from patients with nasopharyngeal carcinoma and healthy donors.
    Chen MR; Yang JF; Hsu TY; Liu MY; Chen JY; Yang CS
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1996 May; 29(2):65-79. PubMed ID: 10592788
    [TBL] [Abstract][Full Text] [Related]  

  • 45. EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma.
    Chan KH; Gu YL; Ng F; Ng PS; Seto WH; Sham JS; Chua D; Wei W; Chen YL; Luk W; Zong YS; Ng MH
    Int J Cancer; 2003 Jul; 105(5):706-9. PubMed ID: 12740922
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epstein-Barr Virus: Clinical Diagnostics.
    Niller HH; Bauer G
    Methods Mol Biol; 2017; 1532():33-55. PubMed ID: 27873265
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Evaluation of PCR results in the diagnosis of Epstein-Barr virus infections].
    Karadağ Geçgel S; Ersoy A; Sevinir BB; Sınırtaş M; Göral G
    Mikrobiyol Bul; 2012 Oct; 46(4):594-606. PubMed ID: 23188573
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epstein-Barr virus and disease activity in multiple sclerosis.
    Buljevac D; van Doornum GJ; Flach HZ; Groen J; Osterhaus AD; Hop W; van Doorn PA; van der Meché FG; Hintzen RQ
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1377-81. PubMed ID: 16170080
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduced Transplacental Transfer of a Subset of Epstein-Barr Virus-Specific Antibodies to Neonates of Mothers Infected with Plasmodium falciparum Malaria during Pregnancy.
    Ogolla S; Daud II; Asito AS; Sumba OP; Ouma C; Vulule J; Middeldorp JM; Dent AE; Mehta S; Rochford R
    Clin Vaccine Immunol; 2015 Nov; 22(11):1197-205. PubMed ID: 26376931
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression and purification of an Epstein-Barr virus encoded 23-kDa protein and characterization of its immunological properties.
    Reischl U; Gerdes C; Motz M; Wolf H
    J Virol Methods; 1996 Mar; 57(1):71-85. PubMed ID: 8919825
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of Epstein-Barr virus-specific antibodies by means of baculovirus-expressed EBV gp125.
    Sánchez-Martínez D; Patton JL; Stewart JA; Pellett PE
    J Virol Methods; 1995 Mar; 52(1-2):145-53. PubMed ID: 7769027
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The association between anti-EBNA-1 IgG and multiple sclerosis clinical disease activity.
    Bahreini SA; Zahednasab H; Saadatnia M; Jabalameli MR
    Eur J Neurol; 2010 Oct; 17(10):e95; author reply e96. PubMed ID: 20636367
    [No Abstract]   [Full Text] [Related]  

  • 53. Application of a commercial immunoblot to define EBV IgG seroprofiles.
    de Ory F; Guisasola E; Tarragó D; Sanz JC
    J Clin Lab Anal; 2015 Jan; 29(1):47-51. PubMed ID: 24687237
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of the Epstein-Barr virus latent membrane protein (LMP) in insect cells and detection of antibodies in human sera against this protein.
    Chen HF; Kevan-Jah S; Suentzenich KO; Grässer FA; Mueller-Lantzsch N
    Virology; 1992 Sep; 190(1):106-15. PubMed ID: 1326801
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [When EBV serology needs a blot to conclude: a case report].
    Périllaud-Dubois C; Bouthry E; Kounis I; Roque-Afonso AM; Vauloup-Fellous C
    Ann Biol Clin (Paris); 2022 Jul; 80(4):385-388. PubMed ID: 36099348
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of Epstein-Barr virus membrane antigen gp350/220 in E. coli and in insect cells.
    Nuebling CM; Buck M; Boos H; von Deimling A; Mueller-Lantzsch N
    Virology; 1992 Nov; 191(1):443-7. PubMed ID: 1329330
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Application of checkerboard immunoblotting (CBIB) to the detection of anti-viral IgG in human serum.
    Craig WY; Poulin SE; Dorsett PH; Ledue TB; Ritchie RF
    J Clin Lab Anal; 1993; 7(4):203-8. PubMed ID: 8360795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serological interpretation--theoretical limits to information from blocking.
    Hoover DN; Wohlgemuth A
    Math Biosci; 1990 Feb; 98(1):127-42. PubMed ID: 2134496
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serological diagnosis of Epstein-Barr virus infection: Problems and solutions.
    De Paschale M; Clerici P
    World J Virol; 2012 Feb; 1(1):31-43. PubMed ID: 24175209
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epstein-Barr Virus and Systemic Autoimmune Diseases.
    Houen G; Trier NH
    Front Immunol; 2020; 11():587380. PubMed ID: 33488588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.